coxsackieviru
nonenvelop
rna
viru
picornavirida
famili
implic
rang
diseas
includ
myocard
type
diabet
asept
mening
caus
symptomat
infect
year
unit
state
howev
major
human
infect
mild
asymptomat
capsid
form
viral
protein
bind
coxsackieviru
adenoviru
receptor
car
requir
infect
polar
epitheli
cell
infect
requir
addit
attach
receptor
decayacceler
factor
daf
car
sequest
tight
junction
car
express
low
nonpolar
cell
line
rd
chines
hamster
ovari
cho
cell
strain
bind
daf
evolv
use
addit
factor
daf
heparan
sulfat
hs
aid
attach
effici
rna
viru
replic
error
prone
give
rise
genet
divers
viral
popul
facilit
emerg
variant
alter
properti
includ
cell
attach
potenti
appropri
amount
viral
popul
divers
thought
aid
viral
adapt
chang
host
environ
requir
full
virul
vivo
viral
popul
encount
select
pressur
distinct
viral
variant
emerg
exampl
mani
virus
use
laboratori
today
cell
cultureadapt
variant
cell
cultur
adapt
reduc
virul
mani
virus
frequent
basi
liveattenu
vaccin
develop
cultureadapt
variant
show
chang
affin
glycosaminoglycan
gag
sulfat
polysaccharid
includ
hs
heparin
gag
present
ubiquit
cell
surfac
shown
virus
mani
differ
famili
interact
gag
aid
viral
attach
viral
affin
gag
import
determin
tissu
tropism
pathogen
examin
replic
pathogenesi
mice
mani
studi
use
peripher
inject
bypass
normal
oral
rout
infect
deliveri
method
replic
effici
oral
inocul
mice
oral
inocul
immunocompet
mice
develop
diseas
replic
effici
mice
lack
interferon
alphabeta
receptor
ifnar
immun
defici
mice
ideal
studi
seek
understand
innat
adapt
respons
viral
infect
therefor
better
model
system
oral
infect
need
sinc
effect
impart
intestin
microbiota
uncov
use
natur
oral
infect
rout
studi
identifi
largeplaqu
variant
emerg
oral
inocul
mice
found
singl
mutat
protein
suffici
format
larg
plaqu
character
variant
vitro
vivo
found
mutant
growth
defect
tissu
cultur
pathogen
wildtyp
wt
mice
also
explor
factor
promot
emerg
largeplaqu
variant
basi
largeplaqu
format
mechan
underli
differ
viral
replic
pathogenesi
examin
replic
gastrointestin
tract
oral
inocul
immunodefici
ifnar
knockout
mice
pfu
neutralredlabel
wt
mice
shed
unrepl
inoculum
viru
fece
difficult
quantifi
viral
replic
intestin
first
day
oral
inocul
avoid
problem
examin
viral
replic
use
lightsensit
neutralredlabel
viru
viru
propag
presenc
neutral
red
dye
sensit
lightinduc
inactiv
rna
crosslink
lose
light
sensit
upon
replic
dark
insid
mice
facilit
assess
replic
differenti
inoculum
viru
replic
viru
fece
fecal
sampl
collect
h
postinfect
hpi
viru
titer
determin
plaqu
assay
use
agar
overlay
fig
hpi
two
mice
shed
replic
viru
mice
shed
replic
viru
hpi
fig
surprisingli
plaqu
morpholog
differ
inoculum
observ
fecal
sampl
titer
plate
fig
suggest
variant
emerg
follow
viral
replic
mice
inde
fecal
viru
plaqu
larg
hpi
larg
hpi
examin
frequenc
largeplaqu
virus
inoculum
determin
whether
largeplaqu
variant
present
prior
inocul
mice
found
inoculum
plaqu
largeplaqu
phenotyp
suggest
largeplaqu
variant
exist
low
level
inoculum
enrich
follow
replic
gut
determin
factor
contribut
emerg
largeplaqu
variant
use
differ
inocul
rout
examin
plaqu
morpholog
viru
differ
tissu
immunocompet
immunodefici
mice
mice
immunocompet
ifnar
mice
oral
intraperiton
ip
intramuscularli
im
inocul
pfu
respect
fecal
sampl
collect
oral
inocul
mice
hpi
liver
heart
spleen
harvest
ip
inocul
mice
hpi
muscl
liver
harvest
im
inocul
mice
hpi
measur
viru
plaqu
size
quantifi
percentag
larg
plaqu
differ
tissu
fig
first
found
largeplaqu
variant
ifnar
mice
mice
increas
emerg
largeplaqu
viru
immunocompet
mice
correl
reduc
viral
replic
indic
increas
select
pressur
may
drive
emerg
largeplaqu
variant
second
largeplaqu
variant
present
fece
oral
inocul
mice
viscer
tissu
ip
im
inocul
mice
muscl
im
inocul
mice
hypothes
increas
select
pressur
intestin
periton
caviti
facilit
emerg
largeplaqu
variant
andor
largeplaqu
variant
fit
advantag
select
tissu
overal
result
suggest
largeplaqu
variant
exist
low
level
inoculum
enrich
follow
viral
replic
sever
tissu
infect
mice
identifi
mutat
respons
largeplaqu
phenotyp
isol
six
individu
largeplaqu
virus
mous
fece
perform
plaqu
purif
gener
largeplaqu
fecal
isol
sampl
extract
rna
perform
revers
transcript
rt
pcr
sequenc
product
consensu
sequenc
sequenc
capsidcod
region
rational
major
chang
plaqu
size
frequent
map
capsid
protein
sequenc
align
reveal
sever
silent
point
mutat
two
amino
acid
chang
capsidcod
region
larg
plaqu
sequenc
align
reveal
amino
acid
variabl
posit
present
mani
genbank
sampl
howev
highli
conserv
among
coxsackievirus
echovirus
fig
locat
virion
surfac
near
daf
bind
site
fig
use
revers
genet
clone
infecti
clone
found
suffici
largeplaqu
phenotyp
fig
recent
et
al
identifi
polymorph
posit
includ
emerg
follow
viral
passag
human
lung
cell
therefor
may
affect
viral
replic
differ
cell
type
suffici
largeplaqu
phenotyp
examin
properti
virus
character
mutant
first
compar
growth
wt
cell
cultur
use
singlecycl
growth
curv
assay
three
human
cell
line
hela
rd
two
rodent
cell
line
infect
multipl
infect
moi
viral
titer
determin
time
mutant
demonstr
growth
defect
cell
line
fig
b
see
fig
supplement
materi
furthermor
wt
mutant
replic
better
human
cell
line
rodent
cell
line
cell
line
differ
level
receptor
express
therefor
hypothes
replic
differ
wt
mutant
may
due
alter
cell
attach
receptor
bind
determin
mutant
growth
defect
cell
cultur
first
examin
cell
attach
cell
attach
assay
incub
hela
rd
cell
layer
facilit
bind
intern
wash
quantifi
cellassoci
label
mutant
show
significantli
reduc
attach
hela
cell
fig
wt
show
limit
attach
rd
cell
therefor
effici
viral
attach
correl
growth
cell
cultur
next
examin
whether
bind
car
daf
differ
wt
mutant
wt
mutant
incub
nitrocellulos
membran
contain
immobil
human
murin
car
hcar
mcar
respect
human
murin
daf
hdaf
mdaf
respect
wash
amount
viru
bound
quantifi
phosphorimag
analysi
found
wt
mutant
bound
hcar
mcar
equival
see
fig
supplement
materi
neither
viru
bound
hdaf
mdaf
data
shown
alter
bind
known
proteinac
receptor
could
explain
attach
defect
mutant
quantifi
viral
bind
gag
first
perform
cell
attach
assay
three
cell
line
deriv
cell
differ
level
hs
surfac
knockout
host
protein
involv
gag
synthesi
gagneg
hsneg
hs
mutant
show
significantli
less
attach
cell
wt
show
attach
compar
wt
three
cell
line
fig
data
indic
mutant
may
alter
bind
gag
second
treat
cell
heparinas
remov
gag
examin
viral
attach
heparinas
treatment
reduc
attach
wt
cell
littl
effect
mutant
attach
fig
third
quantifi
bind
gag
direct
method
heparinagaros
pulldown
assay
incub
heparinagaros
resin
control
streptavidinagaros
resin
h
wash
resinassoci
quantifi
found
mutant
bound
less
effici
heparinagaros
wt
fig
basi
reduc
bind
mutant
heparinagaros
previou
studi
show
sulfat
glycan
agar
inhibit
plaqu
format
virus
hypothes
wt
bind
sulfat
glycan
agar
overlay
reduc
plaqu
size
convers
hypothes
mutant
plaqu
format
would
inhibit
sulfat
glycan
agar
test
examin
plaqu
size
wt
mutant
use
agar
versu
agaros
overlay
presenc
ad
hs
heparin
agaros
contain
low
level
sulfat
glycan
wt
mutant
gener
similars
larg
plaqu
agaros
overlay
addit
hs
heparin
overlay
reduc
wt
plaqu
size
mutant
plaqu
size
see
fig
supplement
materi
taken
togeth
data
suggest
mutant
reduc
bind
sulfat
glycan
facilit
format
larg
plaqu
presenc
sulfat
glycan
reduc
attach
cell
surfac
gag
growth
cell
cultur
given
mutant
emerg
follow
replic
mice
hypothes
may
fit
advantag
vivo
test
hypothesi
first
examin
viral
replic
mice
oral
inocul
pfu
wt
mutant
fecal
sampl
collect
hpi
titer
determin
plaqu
assay
mutant
higher
viral
titer
fece
wt
especi
earli
time
point
fig
sinc
shown
previous
wt
limit
replic
immunocompet
mice
wonder
whether
mutant
would
enhanc
replic
ifnar
mice
test
oral
inocul
ifnar
mice
observ
mutant
replic
effici
wt
fig
also
examin
viral
titer
variou
tissu
oral
inocul
ifnar
mice
hpi
mutant
titer
significantli
higher
wt
titer
mous
tissu
examin
fig
viral
titer
low
ifnar
mous
tissu
mutant
titer
significantli
higher
wt
titer
leg
muscl
indic
mutant
capabl
dissemin
bodi
site
distant
gut
immunocompet
anim
fig
result
indic
mutant
enhanc
replic
system
dissemin
oral
inocul
mice
includ
immunocompet
mice
examin
virul
wt
versu
mutant
monitor
surviv
mice
follow
infect
via
differ
inocul
rout
infect
ifnar
mice
oral
pfu
ip
pfu
im
pfu
fig
first
found
ifnar
mice
succumb
infect
regardless
viru
inocul
rout
second
found
mice
suscept
im
infect
pfu
least
suscept
oral
infect
pfu
third
found
mutant
mice
lower
surviv
rate
wt
mice
summari
mutant
replic
dissemin
effici
ifnar
mice
pathogen
wt
mice
determin
caus
death
mice
understand
mutant
pathogen
wt
examin
liver
patholog
wess
et
al
demonstr
mice
develop
liver
patholog
oral
inocul
mice
pfu
wt
mutant
collect
blood
hpi
measur
serum
protein
level
harvest
liver
hpi
histolog
analysi
first
measur
level
alanin
aminotransferas
alt
marker
liver
damag
serum
alt
level
low
hpi
mice
fig
howev
alt
level
significantli
elev
hpi
mice
infect
mutant
compar
uninfect
control
mice
infect
wt
higher
alt
level
uninfect
mice
mice
infect
mutant
higher
alt
level
uninfect
mice
second
perform
histolog
analysi
liver
tissu
harvest
mice
hpi
shown
fig
supplement
materi
mice
infect
mutant
sever
liver
patholog
uninfect
wt
mice
histolog
examin
reveal
hepat
cell
necrosi
extens
polymorphonuclear
cell
infiltr
hpi
mutant
mice
moder
polymorphonuclear
cell
infiltr
observ
wt
mice
agreement
wess
et
al
data
suggest
mice
develop
liver
damag
furthermor
data
suggest
mice
infect
mutant
liver
damag
wt
anim
enhanc
liver
damag
observ
mutant
mice
hypothes
mutant
may
increas
home
liver
test
ip
inject
mice
wt
mutant
collect
heart
liver
spleen
hpi
quantifi
amount
tissueassoci
viru
scintil
count
wt
mutant
present
equival
level
heart
spleen
mutant
present
liver
fig
fact
averag
half
inject
mutant
found
liver
effect
observ
liver
harvest
hpi
hour
singl
cycl
viral
replic
occur
elev
amount
mutant
found
liver
could
due
increas
bind
liver
tissu
andor
increas
dissemin
liver
distinguish
possibl
quantifi
bind
wt
versu
mutant
liver
tissu
homogen
mice
ex
vivo
found
equival
bind
wt
mutant
liver
tissu
homogen
fig
therefor
data
suggest
mutant
virion
dissemin
liver
effici
wt
virion
errorpron
rna
replic
rna
virus
gener
mutat
everi
singl
cycl
propag
select
pressur
dictat
variant
present
popul
studi
discov
emerg
mutant
vivo
examin
properti
vitro
vivo
use
platform
understand
viral
adapt
factor
influenc
emerg
variant
mani
virus
attach
cell
bind
hs
gag
virus
gag
bona
fide
receptor
virus
nonglycan
proteinac
receptor
bind
gag
enhanc
attach
gag
commonli
interact
viral
particl
via
posit
charg
amino
acid
lysin
arginin
therefor
amino
acid
chang
observ
slightli
unusu
possibl
chang
asparagin
tyrosin
disrupt
gag
bind
nearbi
site
viral
capsid
noncanon
gagcapsid
interact
occur
acquisit
hs
bind
common
cell
cultur
adapt
sever
virus
sever
case
cell
cultur
adapt
bind
hs
attenu
virus
vivo
exampl
cell
cultur
adapt
footandmouth
diseas
viru
select
virus
bind
hs
virus
attenu
cattl
cell
cultureadapt
vaccin
strain
chikungunya
viru
attenu
increas
gag
bind
dengu
viru
variant
reduc
hs
bind
caus
sever
diseas
mice
reduc
clearanc
serum
similarli
laboratori
sindbi
viru
strain
bind
hs
howev
hsbind
sindbi
viru
strain
attenu
mice
interestingli
byrn
et
al
isol
largeplaqu
variant
sindbi
viru
mice
inocul
hsbind
strain
largeplaqu
variant
bound
hs
less
effici
virul
mice
nonhsbind
variant
increas
viremia
decreas
clearanc
serum
perhap
reduc
clearanc
heparinbind
protein
host
sindbi
viru
result
reminisc
result
result
demonstr
wt
plaqu
format
inhibit
substanc
like
sulfat
glycan
agar
wherea
mutant
importantli
use
agaros
rather
agar
plaqu
assay
overlay
would
observ
emerg
mutant
mice
perhap
explain
group
yet
report
emerg
variant
anim
studi
identifi
emerg
mutant
obviou
phenotyp
chang
plaqu
size
possibl
even
like
emerg
variant
occur
frequent
anim
may
miss
lack
observ
phenotyp
emerg
largeplaqu
variant
vari
use
differ
inocul
rout
saw
largeplaqu
variant
emerg
fecal
virus
oral
inocul
mice
tissu
ip
inject
mice
muscl
tissu
im
inject
mice
howev
observ
largeplaqu
virus
liver
im
inject
mice
addit
largeplaqu
variant
emerg
ifnar
mice
mice
result
suggest
increas
select
pressur
intestin
periton
caviti
may
facilit
emerg
largeplaqu
variant
particularli
immunocompet
mice
altern
possibl
mutant
fit
advantag
certain
tissu
mutant
enhanc
replic
pathogenesi
mice
regardless
inocul
rout
know
whether
gagbind
defici
mutant
suffici
enhanc
replic
pathogenesi
effect
contribut
agreement
previou
studi
found
mice
develop
liver
patholog
upon
infect
liver
patholog
sever
mice
infect
mutant
potenti
mutant
increas
dissemin
liver
fig
whether
increas
viral
shed
mice
inocul
oral
mutant
due
alter
viral
dissemin
liver
tissu
unknown
possibl
enhanc
replic
pathogenesi
mutant
specif
mice
sinc
variant
observ
human
clinic
isol
howev
mutant
pathogen
wt
oral
inocul
immunodefici
mice
mutant
replic
well
oral
inocul
immunocompet
mice
even
dissemin
muscl
tissu
may
use
new
model
system
examin
replic
pathogenesi
use
natur
rout
infect
hela
cell
propag
dulbecco
modifi
eagl
medium
dmem
supplement
calf
serum
cell
mutant
cho
cell
obtain
jeffrey
esko
univers
california
san
diego
maintain
supplement
fetal
bovin
serum
human
rhabdomyosarcoma
rd
cell
cell
cell
murin
cell
maintain
dmem
supplement
fetal
bovin
serum
nanci
infecti
clone
obtain
marco
vignuzzi
pasteur
institut
pari
franc
receiv
reinhard
kandolf
version
nanci
bind
hs
stock
prepar
hela
cell
cotransfect
infecti
clone
plasmid
plasmid
express
rna
polymeras
viru
titer
determin
plaqu
assay
hela
cell
previous
describ
agar
final
concentr
becton
dickinson
use
plaqu
assay
overlay
unless
otherwis
indic
plaqu
size
quantifi
imagej
softwar
determin
whether
fecal
virus
inputinoculum
viru
viru
undergon
replic
use
neutralredlabel
lightsensit
describ
previous
determin
percentag
replic
viru
sampl
process
dark
portion
light
expos
percentag
replic
viru
calcul
divid
lightexpos
number
pfuml
nonlightexpos
number
pfuml
multipli
result
prepar
previous
describ
specif
activ
stock
approxim
pfucpm
six
individu
plaqu
gener
fecal
sampl
plaqu
purifi
gener
independ
fecal
isol
viral
rna
isol
purifi
rneasi
minikit
qiagen
rtpcr
perform
superscript
ii
revers
transcriptas
invitrogen
use
primer
cgccacggacgaggta
gener
cdna
pcr
perform
primer
pair
cover
code
region
ie
sens
primer
gctgcccgatgctttgt
antisens
primer
ggccgaaccacagaacataaac
sens
primer
gcaatatgacgtcacaccagagat
antisens
primer
agggctgttgagtacttgttatga
sens
primer
actaccggtttgttgcttcagatc
antisens
primer
ctactagacctggtccttcaaacga
pcr
product
sequenc
univers
texa
ut
southwestern
sequenc
core
six
isol
contain
two
amino
acid
chang
atot
mutat
posit
ctog
mutat
posit
gtoc
mutat
posit
well
silent
point
mutat
posit
highli
variabl
sequenc
focus
effort
fragment
contain
mutat
gener
bsiwibglii
digest
rtpcr
product
one
fecal
isol
fragment
clone
new
nanci
plasmid
nucleotid
bsiwi
nucleotid
bglii
new
plasmid
sequenc
confirm
mutat
pcrgener
region
largeplaqu
phenotyp
new
clone
confirm
plaqu
assay
structur
fig
modifi
previous
determin
crystal
structur
protein
data
bank
code
sequenc
region
near
residu
differ
virus
align
multiplesequ
structur
align
server
sixcentimet
plate
seed
hela
rd
cho
cell
plate
inocul
wt
mutant
moi
min
incub
inoculum
aspir
cell
cell
monolay
wash
ml
fresh
medium
ad
h
infect
cell
trypsin
pellet
releas
intracellular
viru
cell
pellet
freezethaw
three
time
viru
titer
determin
plaqu
assay
hela
cell
data
compar
input
stock
titer
set
cpm
incub
hela
rd
cho
cell
min
facilit
viral
bind
cell
wash
three
time
cold
phosphatebuff
salin
pb
trypsin
quantifi
scintil
counter
certain
experi
cell
treat
uml
heparinas
sigma
aldrich
mm
phosphat
buffer
ph
contain
nacl
mm
kcl
mm
mm
glucos
fetal
calf
serum
bovin
serum
albumin
min
prior
viral
attach
assay
cpm
mix
heparin
agaros
resin
sigma
aldrich
streptavidin
agaros
resin
sigma
aldrich
sampl
incub
h
follow
incub
resin
pellet
centrifug
g
min
resin
wash
three
time
pb
pb
supplement
resinassoci
radioact
quantifi
scintil
count
data
express
percentag
input
count
per
minut
resinassoci
count
per
minuteinput
count
per
minut
car
daf
bind
assay
human
r
system
murin
car
us
biolog
human
r
system
murin
daf
sino
biolog
immobil
nitrocellulos
membran
membran
incub
cpm
h
membran
wash
membraneassoci
radioact
quantifi
phosphorimag
analysi
anim
handl
accord
guid
care
laboratori
anim
nation
institut
health
mous
studi
perform
ut
southwestern
anim
welfar
assur
use
protocol
approv
local
institut
anim
care
use
committe
manner
design
minim
pain
anim
exhibit
sever
diseas
euthan
immedi
isofluran
pvr
ifnar
pvr
mice
obtain
koik
tokyo
japan
experiment
mice
male
experi
shown
fig
mice
oral
inocul
pfu
neutralredlabel
lightsensit
fecal
sampl
collect
dark
experi
shown
fig
mice
oral
ip
inocul
pfu
wt
im
inocul
pfu
wt
tissu
muscl
liver
heart
andor
spleen
harvest
hpi
fecal
sampl
collect
oral
inocul
mice
hpi
experi
shown
fig
mice
oral
inocul
pfu
inocul
ip
im
pfu
pfu
respect
tissu
sampl
process
previous
describ
experi
shown
fig
mice
oral
inocul
pfu
blood
collect
hpi
cheek
bleed
hpi
heart
punctur
follow
heart
punctur
mice
perfus
paraformaldehyd
liver
tissu
collect
fix
paraformaldehyd
h
hematoxylinandeosin
h
e
stain
perform
ut
southwestern
molecular
patholog
core
alt
quantif
serum
separ
centrifug
alt
concentr
determin
enzymelink
immunosorb
assay
elisa
mybiosourc
accord
manufactur
instruct
experi
shown
fig
mice
inocul
ip
wt
mutant
cpm
tissu
collect
hpi
quantif
scintil
counter
case
fece
tissu
sampl
process
prior
viral
titer
assay
scintil
count
previous
describ
experi
shown
fig
fresh
tissu
homogen
bullet
blender
homogen
next
advanc
inc
averil
park
ny
prior
incub
cpm
wt
mutant
incub
tissu
wash
pb
tissueassoci
radioact
quantifi
scintil
count
data
throughout
shown
mean
standard
error
mean
differ
group
examin
unpair
twotail
student
test
p
consid
statist
signific
analys
perform
graph
pad
prism
softwar
graphpad
softwar
la
jolla
ca
cours
studi
saw
largeplaqu
variant
emerg
mice
unexpectedli
found
mutant
viru
increas
replic
virul
mice
upon
observ
enhanc
virul
viru
consult
ut
southwestern
biolog
chemic
safeti
offic
determin
exist
anim
biosafeti
level
protocol
use
polioviru
work
appropri
experi
